<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> (AIS) and sinovenous <z:mp ids='MP_0005048'>thrombosis</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e>) are relatively rare events in children </plain></SENT>
<SENT sid="1" pm="."><plain>The contribution of prethrombotic disorders to the etiology of these entities has not been completely elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVES: To determine the frequency of inherited and acquired prethrombotic disorders in a pediatric population with AIS and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e> and to report clinical and radiological features </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: From May 1992 to April 1997, 30 consecutive children with AIS and 10 children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e> were assisted at a single institution </plain></SENT>
<SENT sid="4" pm="."><plain>Hemostatic evaluation was performed for <z:hpo ids='HP_0000001'>all</z:hpo> the children </plain></SENT>
<SENT sid="5" pm="."><plain>Evaluation included the following assays: protein C, protein S, antithrombin, plasminogen, activated protein C resistance, <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e>, and the detection of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Data concerning baseline demographics, risk factors, presenting features, family history of <z:mp ids='MP_0005048'>thrombosis</z:mp>, and radiological findings were also recorded </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: One or more prethrombotic disorders were present in 9 children (30%) with AIS (inherited <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e>, 2 patients; inherited <z:hpo ids='HP_0005543'>protein C deficiency</z:hpo>, 1 patient; acquired <z:e sem="disease" ids="C0272375" disease_type="Disease or Syndrome" abbrv="">antithrombin deficiency</z:e>, 2 patients; <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, 3 patients; and <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and plaminogen deficiency, 1 patient) and in 5 children (50%) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e> (inherited <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e>, 1 patient; acquired <z:e sem="disease" ids="C0272375" disease_type="Disease or Syndrome" abbrv="">antithrombin deficiency</z:e>, 3 patients; and <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, 1 patient) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Most children studied presented both a variety of risk factors for <z:mp ids='MP_0005048'>thrombosis</z:mp> and concomitant prethrombotic disorders </plain></SENT>
<SENT sid="9" pm="."><plain>Therefore, a complete hemostatic evaluation for <z:hpo ids='HP_0000001'>all</z:hpo> children with AIS and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e> should be performed, despite the presence of obvious clinical risk factors or lack of family history of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>